Infertility Clinical Trial
Official title:
Impact of Low Versus Atmospheric Oxygen Tension on Human Embryo Development : A Prospective Randomized Study
In mammals, uterine environment is at low oxygen concentration (2-8% O2). Thus, human embryo culture under low O2 tension (5%) is now recommended by European Society of Human Reproduction and Embryology (ESHRE) revised guidelines for good practices in in vitro fertilization (IVF) labs. Indeed, hypoxia seems to improve embryo quality at cleavage and blastocyst stages, presumably by reducing damages of oxidative stress (OS). Nevertheless, recent meta-analyses concluded only with a low evidence to a superiority of hypoxia on IVF/ICSI outcomes. Furthermore, a study on mouse embryos suggested a negative impact of OS only at cleavage stage. The aim of the present prospective randomized study was to investigate this hypothesis for the first time in human embryos.
In mammals, uterine environment is at low oxygen tension, between 2 and 8% O2 . However, most
IVF labs perform embryo culture at atmospheric tension (around 20% O2). Several randomized
studies in human embryos have reported the superiority of hypoxia (5%) in terms of embryo
quality and blastulation rates. This fact might be explained by a more physiological
environment, probably inducing a decrease in oxidative stress (OS), which has a harmful
impact on embryo development. Other studies have also suggested that before compaction, OS
damages might be irreversible.
Wale et Gardner have investigated this impact of oxygen tension on mouse embryo development,
by comparing four culture conditions: (i) group 1: culture exclusively at 5% O2 ; (ii) group
2: culture at 5% from Day 0 to Day 2, then at 20% from Day 2 to Day 4; (iii) group 3: at 20%
then at 5% from Day 2; (iv) and group 4: culture exclusively at 20% Interestingly, no
difference in terms of blastulation had been reported between groups 1 and 2, suggesting the
OS might impact only at cleavage stage, and that switching culture under atmospheric
conditions from Day 2/3 might not influence embryo development thereafter.
Hence, all those investigations suggest that embryo culture using trigas incubators (5% O2,
6% CO2 and 89% N2) would be preferable. However, this system is very expensive, notably due
to a high N2 consumption, and requires a more complicated logistics (e.g. N2 levels
monitoring). Yet, Wale and Gardner's results imply that sequential culture conditions (trigas
from Day 0 to Day 2/3, then conventional incubator at 20% O2 until blastocyst stage) could be
an valuable option, reducing the costs and, essentially, without any detrimental impact on
embryo development.
The present study has two main objectives: (i) to confirm the improvement in embryo quality
under low oxygen tension and (ii) to demonstrate the negative impact of OS only at cleavage
stage in human embryos, as assumed by Wale and Gardner. For that purpose, we designed an
original prospective randomized study comparing three culture conditions: (i) culture
excusively at 20% O2 (Day 0 to Day 6) (Group A); (ii) culture exclusively at 5% O2 (Day 0 to
Day 6) (Group B); (iii) culture at 5% from Day 0 to Day 3, then at 20% from Day 3 to Day 6)
(Group C). Inclusion criteria and outcome measures are detailed in the following sections.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |